FDA clearance received for ZEUS dIFine® automated IFA imaging and pattern recognition system
ZEUS Scientific Announces FDA Clearance for our
ZEUS dIFine® IFA Imaging and Pattern Recognition System
The U.S. Food and Drug Administration (FDA) has cleared ZEUS Scientific’s dIFine digital immunofluorescence system for use with ZEUS’s ANA HEp-2 indirect fluorescent antibody (IFA) assay.
The FDA-cleared ZEUS dIFine digital immunofluorescence system is the next generation in IFA imaging and pattern recognition. An automated digital scanner with intelligent software, ZEUS dIFine quickly delivers positive/negative results and has been programmed to suggest eight common ANA patterns*: homogenous, speckled, centromere, nucleolar, nuclear dots, nuclear membrane, cytoplasmic (ribosomal) and cytoplasmic (mitochondrial).
With so many user-friendly features you must see it to believe it!
Pair our top tier IFA ANA HEp-2 product with our dIFine system to take your ANA IFA testing to the next level:
- Get fast results: scan and analyze 8 slides (96 wells) in under an hour
- Instantly identify and locate mitotic cells within the well, a time savings feature not available in any other system
- Programmed to suggest eight common ANA patterns*: homogenous, speckled, centromere, nucleolar, nuclear dots, nuclear membrane, cytoplasmic (ribosomal) and cytoplasmic (mitochondrial)
- Quickly view and validate all negative samples with a single mouse click
- Built-in pattern atlas for side by side comparison with ZEUS proprietary images and ICAP patterns provides an instant reference
Trust ZEUS with your ANA IFA testing needs.
ANA HEp-2 IFA is the American College of Rheumatology (ACR) gold standard method for ANA testing. ZEUS Scientific is a true pioneer in IFA technology and has delivered high quality products since 1976. As a pioneer in IFA technology, ZEUS has continually delivered quality products and expertise in autoimmune serology that laboratories have relied upon since 1976. Our proprietary cell fixation process allows technologists to work with cells containing natural, unaltered antigens.
There is so much more to see.